🇺🇸 FDA

Company profile · Sponsor

Ark

Ark Therapeutics

AARD · NYSE pharma SAN DIEGO, CA, EU
Pipeline
6
Drugs
1
Patents
7

Quick answer

Ark (AARD) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 1 drug, and 7 patents to this profile..

Company facts

Ticker AARD
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, EU
SEC CIK 0001774857

Pipeline (6)

Search pipeline →

  1. ARD-101

    Ark

    Hyperphagia

    phase 3 small molecule on hold

    1 trial

  2. Placebo

    Ark

    Hyperphagia

    phase 3 small molecule on hold

    1 trial

  3. ARD-101

    Ark

    Bariatric Surgery

    phase 2 small molecule completed

    1 trial

  4. ARD-101

    Ark

    Obesity

    phase 2 small molecule completed

    1 trial

  5. ARD-101

    Ark

    Prader-Willi Syndrome

    phase 2 small molecule completed

    1 trial

  6. Low Dose ARD-501

    Ark

    Autism Spectrum Disorder

    phase 2 small molecule completed

    1 trial

Drugs (1)

Search drugs →

  1. adenovirus-mediated herpes simplex virus-thymidine kinase gene

    CEREPRO

Patents (7)

Search patents →

  1. US 12427125

    Method for treating SARS and treating or preventing ARDS

    Expires Mon Sep 25 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12414934

    Combination therapies

    Expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12329739

    Isoflavonoid compounds and methods for the treatment of cancer

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12318364

    Isoflavonoid compositions and methods for the treatment of cancer

    Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12268660

    Oral pharmaceutical formulations of bitter compounds for pulmonary hypertension

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12201593

    Oral pharmaceutical formulations of bitter compounds for asthma

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10835505

    Oral pharmaceutical formulation for weight loss, diabetes and related disorders

    Expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Ark?

Ark (AARD) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 6 pipeline programs, 1 drug, and 7 patents to this profile..

What pipeline programs does Ark sponsor?

We track 6 ClinicalTrials.gov-linked programs for Ark, including ARD-101 and 5 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Ark company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.